Development and Validation of a Multiplex RT-qPCR Panel for Differential Detection of Emerging Porcine Coronaviruses (PEDV, TGEV, PDCoV) in Oral Fluids and Fecal Samples

1. Introduction

Porcine enteric coronaviruses represent a significant threat to global swine production, causing acute gastroenteritis, severe dehydration, and high mortality, particularly in neonatal piglets. The three primary viral agents responsible for this clinical syndrome are Porcine Epidemic Diarrhea Virus (PEDV), Transmissible Gastroenteritis Virus (TGEV), and Porcine Deltacoronavirus (PDCoV). These viruses belong to distinct coronavirus genera (Alphacoronavirus for PEDV and TGEV, Deltacoronavirus for PDCoV) but produce overlapping clinical signs, making differential diagnosis based solely on clinical observation unreliable [1, 2]. The emergence and re-emergence of these pathogens, coupled with their ability to cause substantial economic losses, necessitate the development of rapid, sensitive, and specific diagnostic tools capable of differentiating them in a single reaction.

Traditional diagnostic methods, including virus isolation, electron microscopy, and conventional endpoint RT-PCR, are labor-intensive, time-consuming, and often lack the throughput required for large-scale surveillance [3]. Real-time quantitative reverse transcription PCR (RT-qPCR) has become the gold standard for viral RNA detection due to its high analytical sensitivity, quantitative capacity, and reduced risk of cross-contamination. A multiplex RT-qPCR panel, which incorporates multiple primer-probe sets in a single reaction, offers the advantage of simultaneous detection and differentiation of multiple targets, conserving sample material, reagents, and labor [4, 5].

This article details the systematic development and validation of a multiplex RT-qPCR panel designed for the differential detection of PEDV, TGEV, and PDCoV in two common sample types: oral fluids and fecal samples. Oral fluids have emerged as a practical, non-invasive sample matrix for herd-level surveillance, while fecal samples remain the gold standard for individual animal diagnosis [6, 7]. The discussion encompasses primer and probe design, analytical performance characteristics, challenges associated with co-infections and genetic variability, and recommendations for integration into routine surveillance programs.

2. Assay Design and Optimization

2.1. Target Gene Selection and Primer/Probe Design

The success of a multiplex RT-qPCR assay hinges on the careful selection of target genomic regions. For PEDV, the nucleocapsid (N) gene or the membrane (M) gene are commonly targeted due to their high copy number during infection and relative sequence conservation among circulating strains [8]. For TGEV, the spike (S) gene or the N gene are frequently selected, with the S gene offering the potential to differentiate TGEV from the antigenically related Porcine Respiratory Coronavirus (PRCV), which has a deletion in the S gene [9]. For PDCoV, the N gene or the non-structural protein (nsp) regions, such as nsp10 or nsp14, are preferred targets due to their conservation within the deltacoronavirus genus [10].

Primer and probe sequences must be designed to meet stringent thermodynamic criteria. Melting temperatures (Tm) for primers are typically optimized to fall between 58-60 degrees Celsius, with probes designed to have a Tm 5-10 degrees Celsius higher to ensure stable probe binding before primer extension [11]. Amplicon length is kept short, generally between 70 and 150 base pairs, to maximize amplification efficiency and minimize the impact of RNA degradation in field samples [12]. Each probe is labeled with a distinct fluorophore (e.g., FAM, HEX, Cy5) and a quencher (e.g., BHQ-1, BHQ-2) to allow spectral discrimination within a single channel of a real-time PCR instrument. In silico analysis using BLAST (Basic Local Alignment Search Tool) is performed to confirm the specificity of each primer-probe set against a comprehensive database of swine pathogens and host genomic sequences [13].

2.2. Multiplex Reaction Optimization

The combination of three primer-probe sets in a single reaction introduces the potential for primer-dimer formation, cross-talk between fluorophores, and competitive inhibition of amplification. Optimization of the multiplex reaction is therefore a critical step. Key parameters include the concentration of magnesium chloride, deoxynucleotide triphosphates (dNTPs), and each primer-probe pair. A titration matrix is used to determine the optimal concentration for each set, balancing signal intensity with the absence of non-specific amplification [14].

The reverse transcription step is typically performed using a combination of random hexamers and oligo-dT primers, or a gene-specific primer, to generate cDNA. The use of a one-step RT-qPCR master mix, which combines reverse transcriptase and DNA polymerase in a single buffer system, simplifies the workflow and reduces the risk of contamination [15]. Thermal cycling conditions are standardized, with a reverse transcription step at 50 degrees Celsius for 15-30 minutes, followed by an initial denaturation at 95 degrees Celsius for 2-5 minutes, and then 40-45 cycles of denaturation at 95 degrees Celsius for 10-15 seconds and annealing/extension at 60 degrees Celsius for 30-60 seconds. Fluorescence data are acquired during the annealing/extension step.

An internal positive control (IPC), such as an exogenous RNA transcript or a housekeeping gene (e.g., beta-actin, GAPDH), is incorporated into the multiplex panel to monitor for the presence of PCR inhibitors and to verify the efficiency of nucleic acid extraction [16]. The IPC is amplified using a separate primer-probe set labeled with a fluorophore distinct from the three viral targets.

3. Analytical Validation

3.1. Analytical Sensitivity (Limit of Detection)

Analytical sensitivity, or the limit of detection (LoD), is defined as the lowest concentration of target RNA that can be reliably detected with a probability of 95% [17]. To determine the LoD, synthetic RNA transcripts or quantified viral stocks of PEDV, TGEV, and PDCoV are serially diluted in a background matrix of negative oral fluid or fecal eluate. Each dilution is tested in multiple replicates (e.g., 20 replicates) across several runs. The LoD is calculated using probit regression analysis or by determining the dilution at which 95% of replicates yield a positive result [18].

For a well-optimized multiplex panel, the LoD for each target is typically in the range of 10-100 RNA copies per reaction. The presence of competing targets in a multiplex reaction can sometimes reduce sensitivity compared to a singleplex assay. A comparative analysis of singleplex versus multiplex LoD values is performed to quantify any loss in analytical sensitivity. A less than 10-fold difference in LoD is generally considered acceptable for diagnostic purposes [19].

3.2. Analytical Specificity and Cross-Reactivity

Analytical specificity is assessed by testing the multiplex panel against a panel of nucleic acids extracted from other common swine pathogens. This panel includes, but is not limited to, Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), Porcine Circovirus Type 2 (PCV2), Swine Influenza A Virus (SIV), Porcine Parvovirus (PPV), Porcine Kobuvirus, and Porcine Astrovirus [20]. The assay must demonstrate no amplification signal for any of these non-target pathogens.

Cross-reactivity between the three target viruses is evaluated by testing high concentrations of one target RNA (e.g., PEDV) in the absence of the other two (TGEV, PDCoV). The assay must correctly identify only the target present, with no false-positive signals from the other two channels [21]. This is particularly important for PEDV and TGEV, which share some genetic homology as alphacoronaviruses. The primer and probe sets must be designed to target regions with sufficient sequence divergence to prevent cross-binding.

3.3. Amplification Efficiency and Linearity

Standard curves are generated for each target by amplifying serial ten-fold dilutions of known copy number standards. The cycle threshold (Ct) values are plotted against the log of the input copy number. The slope of the standard curve is used to calculate the amplification efficiency (E) using the formula: E = 10^(-1/slope) - 1. An efficiency between 90% and 110% (slope between -3.6 and -3.1) is considered acceptable [22]. The coefficient of determination (R^2) of the standard curve should be greater than 0.98, indicating a strong linear relationship across the dynamic range of the assay. The dynamic range typically spans 6-8 log10 copies per reaction.

4. Performance on Field Samples

4.1. Sample Collection and Processing

Oral fluids are collected by suspending a clean cotton rope in a pen for 20-30 minutes, allowing pigs to chew on it. The rope is then placed in a plastic bag, and the fluid is wrung out into a collection tube [23]. Fecal samples are collected directly from the rectum or from freshly voided feces. Both sample types are transported to the laboratory on cold packs and processed within 24 hours. Nucleic acid extraction is performed using a commercial magnetic bead-based or silica column-based extraction kit, following the manufacturer's instructions. The extracted RNA is eluted in a low-volume buffer (e.g., 50-100 microliters) to maximize concentration.

4.2. Diagnostic Sensitivity and Specificity

Diagnostic sensitivity and specificity are determined by testing a panel of well-characterized field samples. A reference standard, such as a combination of virus isolation, sequencing, and a validated singleplex RT-qPCR assay, is used to classify samples as true positive or true negative for each virus [24]. The multiplex panel results are then compared to this reference standard.

Diagnostic sensitivity is calculated as the proportion of true positive samples that test positive by the multiplex assay. Diagnostic specificity is calculated as the proportion of true negative samples that test negative. For a robust assay, both values should exceed 95% [25]. Discrepant results are investigated by repeating the extraction and amplification, and by sequencing the amplicon to confirm the presence or absence of the target virus.

4.3. Detection of Co-Infections

Co-infections with two or three of these enteric coronaviruses are common in field settings, particularly in herds experiencing outbreaks of diarrhea [26]. The multiplex panel must be capable of reliably detecting all targets present in a mixed infection. This is validated by spiking negative sample matrices with known concentrations of two or three viral RNAs and confirming that each target is detected with the expected Ct value. The presence of a high titer of one virus can sometimes suppress the amplification of a lower titer virus due to competition for reagents. The assay's tolerance for such competitive inhibition is assessed by testing samples with varying ratios of the three targets [27].

5. Challenges and Considerations

5.1. Genetic Variability

RNA viruses, including coronaviruses, have high mutation rates due to the lack of proofreading activity in their RNA-dependent RNA polymerases. This genetic drift can lead to mismatches in primer or probe binding sites, resulting in reduced assay sensitivity or complete failure to detect emerging strains [28]. Continuous monitoring of circulating viral sequences through public databases (e.g., GenBank) is essential. The primer and probe sets should be designed to target highly conserved genomic regions, and a bioinformatics pipeline should be established to periodically re-evaluate the in silico specificity of the assay against newly reported sequences. If necessary, degenerate bases or modified nucleotides (e.g., locked nucleic acids) can be incorporated into the primers to accommodate sequence variability [29].

5.2. Sample Matrix Effects

Both oral fluids and fecal samples contain complex mixtures of substances that can inhibit reverse transcription and PCR amplification. Inhibitors include bile salts, polysaccharides, heme, and complex polysaccharides from feed [30]. The inclusion of an IPC is critical for identifying samples with significant inhibition. If the IPC fails to amplify, the sample should be re-extracted using a method designed to remove inhibitors, or diluted and re-tested. The extraction protocol should be validated for both sample types to ensure consistent removal of inhibitors and efficient recovery of viral RNA.

5.3. Quantification and Standardization

While RT-qPCR is inherently quantitative, the results are relative to the standard curve used. The use of different standard materials (e.g., synthetic RNA, in vitro transcribed RNA, plasmid DNA) across laboratories can lead to significant variability in reported copy numbers [31]. The establishment of international reference standards for PEDV, TGEV, and PDCoV RNA would greatly facilitate inter-laboratory comparison and harmonization of results. For routine diagnostic purposes, reporting Ct values or semi-quantitative results (e.g., high, medium, low positive) may be more practical than absolute copy numbers.

6. Integration into Surveillance Programs

The validated multiplex RT-qPCR panel is a powerful tool for routine surveillance and outbreak investigation. Oral fluid sampling is particularly well-suited for herd-level monitoring due to its ease of collection and ability to sample a large number of animals simultaneously [32]. Regular testing of oral fluids from different production stages (e.g., farrowing, nursery, finishing) can provide early warning of virus introduction and help track the dynamics of infection within a herd.

Fecal sampling remains important for confirming clinical cases in individual animals, particularly in neonatal piglets where oral fluid collection may be impractical. The ability to differentiate between PEDV, TGEV, and PDCoV in a single test allows for rapid implementation of targeted biosecurity measures and vaccination strategies [33]. For example, the detection of TGEV, which is now less common in many regions but can cause severe disease, would trigger a different response than the detection of PDCoV, which may cause milder clinical signs.

Data generated from the multiplex panel can be integrated with other diagnostic results, such as those from panels for PRRSV and SIV, to provide a comprehensive picture of the pathogen landscape in a swine herd. The workflow for the assay is summarized in Figure 1.

flowchart TD
    A[Sample Collection: Oral Fluids or Feces], > B[Nucleic Acid Extraction]
    B, > C[One-Step Multiplex RT-qPCR]
    C, > D{Signal Detection}
    D, FAM (PEDV), > E[PEDV Positive]
    D, HEX (TGEV), > F[TGEV Positive]
    D, Cy5 (PDCoV), > G[PDCoV Positive]
    D, IPC Channel, > H[IPC Valid]
    H, No, > I[Inhibition Detected: Re-extract or Dilute]
    E & F & G, > J[Interpretation & Reporting]
    I, > B

Figure 1. Workflow for the multiplex RT-qPCR panel for differential detection of PEDV, TGEV, and PDCoV.

7. Conclusion

The development and validation of a multiplex RT-qPCR panel for the differential detection of PEDV, TGEV, and PDCoV represents a significant advancement in swine enteric disease diagnostics. The assay provides a rapid, sensitive, and specific method for identifying and differentiating these three clinically similar pathogens in both oral fluids and fecal samples. Rigorous analytical validation, including assessment of sensitivity, specificity, and robustness, is essential to ensure reliable performance. The incorporation of an IPC and continuous monitoring of genetic variability are critical for maintaining assay accuracy over time. When integrated into routine surveillance programs, this multiplex panel enables timely and informed decision-making for disease control and prevention, ultimately reducing the economic impact of these emerging porcine coronaviruses.

References

[1] Saif, L. J., & Jung, K. (2020). Comparative pathogenesis of enteric coronaviruses in swine. Veterinary Microbiology.

[2] Wang, Q., Vlasova, A. N., Kenney, S. P., & Saif, L. J. (2019). Emerging and re-emerging coronaviruses in pigs. Current Opinion in Virology.

[3] Opriessnig, T., & Halbur, P. G. (2012). Concurrent infections are important for expression of porcine circovirus associated disease. Virus Research.

[4] Mackay, I. M., Arden, K. E., & Nitsche, A. (2002). Real-time PCR in virology. Nucleic Acids Research.

[5] Elnifro, E. M., Ashshi, A. M., Cooper, R. J., & Klapper, P. E. (2000). Multiplex PCR: optimization and application in diagnostic virology. Clinical Microbiology Reviews.

[6] Prickett, J. R., & Zimmerman, J. J. (2010). The development of oral fluid-based diagnostics and applications in veterinary medicine. Animal Health Research Reviews.

[7] Ramirez, A., & Karriker, L. A. (2012). Use of oral fluids for detection of viral pathogens in swine. Journal of Swine Health and Production.

[8] Kim, S. H., Kim, I. J., Pyo, H. M., Tark, D. S., & Song, J. Y. (2007). Multiplex real-time RT-PCR for the detection and differentiation of porcine epidemic diarrhea virus and transmissible gastroenteritis virus. Journal of Virological Methods.

[9] Wesley, R. D., Woods, R. D., & Hill, H. T. (1990). Evidence for a porcine respiratory coronavirus, antigenically similar to transmissible gastroenteritis virus, in the United States. Journal of Veterinary Diagnostic Investigation.

[10] Marthaler, D., Raymond, L., Jiang, Y., Collins, J., Rossow, K., & Rovira, A. (2014). Rapid detection and complete genome sequencing of porcine deltacoronavirus in the United States. Emerging Infectious Diseases.

[11] Bustin, S. A., Benes, V., Garson, J. A., Hellemans, J., Huggett, J., Kubista, M., ... & Wittwer, C. T. (2009). The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clinical Chemistry.

[12] Bustin, S. A., & Nolan, T. (2004). Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction. Journal of Biomolecular Techniques.

[13] Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990). Basic local alignment search tool. Journal of Molecular Biology.

[14] Henegariu, O., Heerema, N. A., Dlouhy, S. R., Vance, G. H., & Vogt, P. H. (1997). Multiplex PCR: critical parameters and step-by-step protocol. BioTechniques.

[15] Wacker, M. J., & Godard, M. P. (2005). Analysis of one-step and two-step real-time RT-PCR using SuperScript III. Journal of Biomolecular Techniques.

[16] Hoorfar, J., Malorny, B., Abdulmawjood, A., Cook, N., Wagner, M., & Fach, P. (2004). Practical considerations in design of internal amplification controls for diagnostic PCR assays. Journal of Clinical Microbiology.

[17] Burd, E. M. (2010). Validation of laboratory-developed molecular assays for infectious diseases. Clinical Microbiology Reviews.

[18] Forootan, A., Sjöback, R., Björkman, J., Sjögreen, B., Linz, L., & Kubista, M. (2017). Methods to determine limit of detection and limit of quantification in quantitative real-time PCR. Biomolecular Detection and Quantification.

[19] Kodani, M., Yang, G., Conklin, L. M., Travis, T. C., Whitney, C. G., Anderson, L. J., ... & Erdman, D. D. (2011). Application of TaqMan low-density arrays for simultaneous detection of multiple respiratory pathogens. Journal of Clinical Microbiology.

[20] Meng, X. J. (2012). Emerging and re-emerging swine viruses. Virus Research.

[21] Toohey-Kurth, K., Reising, M. M., & Killian, M. L. (2020). Guidelines for validation of real-time PCR assays for veterinary diagnostic laboratories. Journal of Veterinary Diagnostic Investigation.

[22] Pfaffl, M. W. (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research.

[23] Bjustrom-Kraft, J., Christopher-Hennings, J., Daly, R., Gerber, P. F., Gresham, T., Johnson, J., ... & Zimmerman, J. (2018). The use of oral fluid diagnostics in swine medicine. Journal of Swine Health and Production.

[24] OIE (World Organisation for Animal Health). (2019). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals.

[25] Saah, A. J., & Hoover, D. R. (1997). "Sensitivity" and "specificity" reconsidered: the meaning of these terms in analytical and diagnostic settings. Annals of Internal Medicine.

[26] Jung, K., & Saif, L. J. (2015). Porcine epidemic diarrhea virus infection: Etiology, epidemiology, pathogenesis and immunoprophylaxis. The Veterinary Journal.

[27] Polz, M. F., & Cavanaugh, C. M. (1998). Bias in template-to-product ratios in multitemplate PCR. Applied and Environmental Microbiology.

[28] Denison, M. R., Graham, R. L., Donaldson, E. F., Eckerle, L. D., & Baric, R. S. (2011). Coronaviruses: an RNA proofreading machine regulates replication fidelity and diversity. RNA Biology.

[29] Latorra, D., Arar, K., & Hurley, J. M. (2003). Design considerations and effects of LNA in PCR primers. Molecular and Cellular Probes.

[30] Wilson, I. G. (1997). Inhibition and facilitation of nucleic acid amplification. Applied and Environmental Microbiology.

[31] Hayden, R. T., Yan, X., Wick, M. T., Rodriguez, A. B., Xiong, X., Ginocchio, C. C., ... & Caliendo, A. M. (2012). Factors contributing to variability of quantitative viral PCR results in proficiency testing samples: a multivariate analysis. Journal of Clinical Microbiology.

[32] Rotolo, M. L., Sun, Y., Wang, C., Giménez-Lirola, L., Baum, D. H., Gauger, P. C., ... & Zimmerman, J. J. (2018). Sampling guidelines for oral fluid-based surveillance of porcine reproductive and respiratory syndrome virus in swine. Journal of Veterinary Diagnostic Investigation.

[33] Stevenson, G. W., Hoang, H., Schwartz, K. J., Burrough, E. R., Sun, D., Madson, D., ... & Yoon, K. J. (2013). Emergence of Porcine epidemic diarrhea virus in the United States: clinical signs, lesions, and viral genomic sequences. Journal of Veterinary Diagnostic Investigation. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.